A Single-arm, Open Label Phase II Study of RAD001 in Soft Tissue Extremity and/or Retroperitoneal Sarcomas.
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2012
At a glance
- Drugs Everolimus (Primary)
- Indications Sarcoma; Soft tissue sarcoma
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 11 Oct 2011 Planned end date changed from 1 Feb 2013 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 11 Oct 2011 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.